|
134. Larsson SC, Bergkvist L, Wolk A. Consumption of sugar and sugar-sweetened foods and the risk of pancreatic cancer in a prospective study . Am J Clin Nutr 2006; 84:1171–6. 135. Prandini A, Tansini G, Sigolo S, Filippi L, Laporta M, Piva G. On the occurrence of aflatoxin M1 in milk and dairy products. Food Chem Toxicol 2009; 47: 984–91. 136. Turner P, Mendy M, Whittle H, Fortuin M, Hall M, Wild C. Hepatitis B infection and aflatoxin biomarker levels in Gambian children. Trop Med Intl Health 2000; 5: 837–41. 137. Rodriguez MA, Cabrera G, Godeas A. Cyclosporine A from a nonpathogenic Fusarium oxysporum suppressing Sclerotinia sclerotiorum . J Appl Microbiol 2006; 100: 575–586. 138. Pitt J, Wild CP, Baan RA et al. Improving Public Health through Mycotoxin Control 2012; Lyon: IARC (IARC Scientific Publications Series, N 158). 139. World Cancer Report 2014 (p.171). 140. M. Valko, C.J. Rhodes, J. Moncol, M. Izakovic, M. Mazur. Free radicals, metals and antioxidants in oxidative stress-induced cancer . Chemico-Biological Interactions 2006; vol 160, issue 1: pp 1–40. 141. G. Unden and J. Bongaert. Alternative respiratory pathways of Escherichia coli: energetics and transcriptional regulation in response to electron acceptors. Biochim et Biophys Acta 1997, 1320, 217–234. 142. Nimptsch K1, Rohrmann S, Kaaks R, Linseisen J. Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Am J Clin Nutr. 2010; 91(5): 1348–58. 143. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354–362. 144. Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Gastroenterol 2006; 20: 633–649. 145. Tsugane S, Gey F, Ichinowatari Y, Miyajima Y, Ishibashi T, Matsushima S, Hirota Y, Inami T, Yamaguchi M, Karita K. Cross-sectional epidemiologic study for assessing cancer risks at the population level I. Study design and participation rate. J Epidemiol 1992; 2: 75–81. 146. Tsugane S, Gey F, Ichinowatari Y, Miyajima Y, Ishibashi T, Matsushima S, Hirota Y, Inami T, Yamaguchi M, Karita K. Cross-sectional epidemiologic study for assessing cancer risks at the population level II. Baseline data and correlation analysis . J Epidemiol 1992; 2: 83–89. — 60 —
|